Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report

Tseng, LW; Chang, JWC; Wu, CE

Wu, CE (通讯作者)，Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Haematol Oncol,Coll Med, 5 Fu Hsing St, Taoyuan 33302, Taiwan.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022; 23 (19):

Abstract

The targeted agents capmatinib and tepotinib provide a new treatment for patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping mu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索